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SUMMARY 
Background: Cancer of the breast is the most common malignancy affecting women in many parts of the world. Its 
early detection has, therefore, become necessary to reduce morbidity and mortality from the disease. In sub-Saharan 
Africa, radiological imaging, histology and management programs are associated with challenges.  
Objectives: This study seeks to assess the validity of clinical diagnosis, mammography and breast ultrasonography in 
the preoperative assessment of suspected breast cancer patients for accurate detection of the disease to enable appro-
priate management. 
Methods: A prospective cross-sectional study was carried out in the Radiology Department of Komfo Anokye Teach-
ing Hospital, Kumasi, Ghana, between November 2007 and July 2008 with a sample size of 103. All patients with a 
clinical suspicion of breast cancer who gave informed consent were recruited, underwent bilateral mammography and 
whole breast ultrasonography and then biopsy for all BIRADS categories 4 or 5 lesions. The histopathology results 
were retrieved to complete the study. 
Result: In this study the definition of malignancy was made using histology as the gold standard. A total of 103 patients 
were recruited for this study with mean age of 55(+15) years, out of which 52 (50.5%) had malignant lesions. The 
overall sensitivity of clinical diagnosis was 50.5%. While the overall sensitivity and specificity for mammogram and 
ultrasound were 73.0%, 80.0% and 100%, 80.4% respectively.  
Conclusion: In conclusion, this study has demonstrated that clinical diagnosis, ultrasound and mammography can 
potentially predict breast cancer disease with considerable sensitivity and specificity. 
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INTRODUCTION 
The accuracy of clinical diagnosis, mammography and 
breast ultrasonography in the preoperative assessment of 
breast cancer is necessary for early diagnosis. It is also to 
allow accurate pre-treatment planning to allow neoadju-
vant chemotherapy or a single surgical intervention with 
clear surgical margins to reduce the incidence of tumour 
recurrence as patients usually abscond after the first sur-
gical intervention. 
 
Cancer of the breast is the most common malignancy af-
fecting women in many parts of the world.1,3,4 About 16% 
of the world's population is covered by registration sys-
tems that produce cancer incidence statistics, while mor-
tality data are available for about 29%.1  
 
Breast cancer incidence and mortality vary by world re-
gions. In general, the incidence is high (greater than 80 
per 100,000) in developed regions of the world and low 
(less than 30 per 100,000), though increasing, in devel-
oping regions; the range of mortality rates is much less 
(6-23 per 100,000) because of the more favorable sur-
vival of breast cancer in high-incidence developed re-
gions.5  
 
The low incidence in developing regions attributed to 
poor and/or lack of cancer registry and data collection 
which has however started improving in the last decade. 
The incidence of female breast cancer is increasing eve-
rywhere.6  
 
This unfavorable trend is due in part to increases in risk 
factors such as decreased childbearing and breast-feed-
ing, increased exogenous hormone exposure, and detri-
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and less physical activity, early menarche and late men-
opause.7,9 On the other hand, mortality is now decreasing 
in many high-risk countries due to a combination of in-
tensified early detection efforts and the introduction of 
mammographic screening, resulting in the diagnosis of 
more smaller, early stage tumors, and advances in treat-
ment.10 In a ten year review in Korle-Bu Teaching Hos-
pital, the commonest cause of cancer death in females 
was malignancies of the breast [Age-Standardized Can-
cer Ratio (ASCAR), 17.24%].4 In Komfo Anokye Teach-
ing Hospital (KATH), Kumasi, Ghana, where this study 
took place, breast cancer forms the highest percentage of 
cancers (23%) in the annual cancer registry at the oncol-
ogy unit for the year 2006. 
 
A realistic strategy for the reduction of breast cancer mor-
tality rates is to accurately diagnose the disease while it 
is still in an early stage. Mass screening for breast cancer, 
using mammography has demonstrated a 30% reduction 
in breast cancer mortality in Western countries11, and has 
also shown a significant 33% reduction in mortality rates 
for the high-risk group in Taiwan.12 In Ghana, there is no 
established national breast screening program, but there 
is however increasing awareness through educational 
campaigns. This awareness has increased the number of 
women seeking medical help with symptoms of breast 
disease.13 It is therefore appropriate for physicians to 
make good clinical judgment to suspect breast cancer 
through clinical history and clinical examination to assist 
in early detection of the disease.  
 
Conventional mammography and sonography of the 
breast are used as routine imaging techniques in diagno-
sis of breast cancer throughout the world. The sensitivity 
of mammographic detection of cancer is high but is re-
duced in women with radiographically dense breasts, be-
cause breast cancers have a radiographic attenuation that 
is similar to that of glandular and fibrous elements (14).14 
The sensitivity of mammography to the index cancer 
ranges from 63% to 98% 15 and has been reported to be 
as low as 30% to 48% in dense breasts (16),16 hence re-
ducing the accuracy of   breast cancer diagnosis by mam-
mography.  
 
Several groups have evaluated the preoperative use of 
supplemental magnetic resonance (MR) imaging17, ultra-
sonography (USG)18, or both19 after mammography to as-
sess the extent of disease within the breast(s). USG is 
very useful in differentiating the breast tumours from 
cystic lesions and is used an as adjunct tool to evaluate 
breast abnormalities found during mammography or 
physical examination. However, Chao et al. 20 have 
shown that USG has a high predictive ability when ex-
amining the breast per study done on Taiwan women. 
However, among high-risk women, USG in combination 
with other methods may play an important role in breast 
cancer imaging. 
 
Also, with scarce radiological and/or economic resources 
for breast imaging in our setting, knowledge of appropri-
ate features of breast cancer on imaging using the most 
cost-effective imaging modalities is essential for detec-
tion of breast cancer early enough for appropriate man-
agement. With increasing use of reliable percutaneous bi-
opsy techniques, a current goal in breast cancer manage-
ment is accurate pre-treatment planning to allow neoad-
juvant chemotherapy or a single definitive surgical pro-
cedure with lymph node sampling. Complete excision of 
malignant foci is the standard, with the goal of achieving 
clear margins of excision. 
 
The purpose of this study was to prospectively assess the 
accuracy of clinical diagnosis, mammography and breast 
Ultrasonography in the preoperative assessment of breast 
cancer with histology as the gold standard. 
 
METHODS 
This was a prospective cross-sectional study using con-
venient sampling and a sample size of 103 patients. The 
study took place in Ghana, in the Radiology Department 
at Komfo Anokye Teaching Hospital (KATH) a 1200-
bed capacity hospital, located in Kumasi, the Regional 
Capital of Ashanti Region with a total projected popula-
tion of 4,780,380 (2000).21  
 
The study took place between November 2007 and July 
2008. The Department has 5 radiologists and 13 resident 
doctors and performs an average of 520 cases annually 
out of which an average of 10% is breast cancers. All pa-
tients coming to the radiology department for breast im-
aging with a clinical suspicion of breast cancer who gave 
informed consent were recruited into the study. All age 
groups were considered, and the inclusion criteria were 
to have some clinical suspicion of malignancy with a re-
quest for breast imaging. Those with no clinical suspicion 
for malignancy and patients who did not give informed 
consent were excluded from the study and this did not 
affect their management or care. 
 
All the participants were interviewed, and a predesigned 
form was used to collect data on their socio-demographic 
status. Data from patients’ notes were also taken to obtain 
their clinical history and clinical examination.  
 
 
At the radiology department, the women enrolled into the 
study underwent bilateral mammography and whole 
breast ultrasonography with the primary request from the 
surgeon being the first to be carried out. Records of find-
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Breast Imaging Reporting and Data System, or BIRADS, 
lexicon (Appendix I). Biopsy was recommended if the 
mammogram or the sonographic findings were adjudged 
to be suspicious or highly suggestive for cancer, in ac-
cordance with (BIRADS) categories 4 or 5. All cases 
with normal or benign radiological features were consid-
ered as normal and did not go through biopsy. 
 
Mammogram was performed using dedicated mammo-
graphic equipment (Mammomat 300 1995, Siemens, 
Germany) and the screen film technique. Conventional 
four-view film mammograms included routine cranio-
caudal and mediolateral oblique views of the breast(s) 
and spot views when needed.  
Bilateral whole-breast ultrasonography was performed 
with knowledge of clinical and mammographic findings. 
All sonograms were obtained using high resolution 
diagnostic ultrasonography equipment (Siemens/Sono-
line Sienna or Siemens/Sonoline G 50) and a 7.5-MHZ 
frequency transducer probe operated by an experienced 
physician.  
 
For the inner breast, scanning was performed with the pa-
tient in the supine position. For the outer breast, the pa-
tient was placed in the contra lateral posterior oblique po-
sition with the ipsilateral arm raised. Survey scanning 
was performed in radial and anti-radial planes. Lesions 
were measured in both radial and anti-radial scanning 
planes and their location noted. Records of findings were 
recorded onto a predesigned form using Breast Imaging 
Reporting and Data System, or BIRADS, lexicon (Ap-
pendix I).   
 
 
Appendix 1 Breast Imaging Reporting and Data System (BIRADS) lexicon  
1. Impression 2. Mammogram Findings/features 3. Ultrasonography Findings/features 
4. Category 0 (needs addi-
tional imaging evalua-
tion)  
5. No diagnosis could be made based on the conventional 
mammogram taken; mostly due to dense breast or sub-
tle changes where no conclusion can be made due to 
findings and hence requires additional imaging like 
spot view or ultrasonography 
6.  
7. Category 1 (negative- 
nothing to comment on)         
8. No abnormality; no malignant or benign features 9. No abnormality was detected; no malignant or be-
nign features. 
10. Category 2 (Benign find-
ing)                     
11. Masses with the following features; Oval or round 
shape mass with Smooth, sharp or well-defined mar-
gins, iso-dense or hypo-dense mass to breast tissue; lu-
cent or fatty content mass; macro calcifications or 
‘popcorn’ calcifications 
12. lesion with the following features; Oval or round 
shape; Smooth, sharp or well-defined margins; hy-
per echoic or mildly hypo echoic to breast tissue 
mass; fatty content in mass; macro calcifications or 
‘popcorn’ calcifications; homogeneous echo tex-
ture; no posterior shadowing; bilateral edge shad-
owing; compressible; longer than taller. 
13. Category 3 (Probably be-
nign finding)      
14. Lesions with more of benign features but showed even 
one of the malignant features were considered to be 
probably benign and required a short-term interval fol-
low-up.  
15. Lesions with more of benign features but showed 
even one of malignant feature were considered to be 
probably benign 
16. Category 4 (Suspicious 
abnormality)    
17. Lesions with more of malignant features and showed 
even one benign feature were considered as suspicious 
of malignancy and needed to be biopsied 
18. Lesions with more of malignant features but showed 
even one of the benign features were considered as 
suspicious of malignancy, and required biopsy. 
19. Category 5 (Highly sug-
gestive of malignancy) 
20. Masses with ill-defined, irregular or obscured margins; 
spiculated or micro lobulated contour or margin; mark-
edly dense; retracted nipple; skin thickening; architec-
tural distortion; pleomorphic micro calcifications. 
21. Lesions with features as follows; ill-defined; irreg-
ular or micro lobulated contour or margin; markedly 
hypo echoic mass; heterogeneous echo texture; 
taller than longer; posterior shadowing; non-com-
pressible. 
Lesions considered suspicious or highly suggestive of 
malignancy on mammography or ultrasonography were 
then sampled for core biopsy or excision biopsies after 
imaging. Preoperative core-needle biopsy was done un-
der sonographic guidance for lesions that were too small 
or non-palpable. For bigger lesions biopsy was done 
blindly without any guidance. Biopsy was performed by 
one of the surgeons or radiologists.  
 
A 14-gauge manual biopsy gun was used to sample le-
sions with a minimum of three passes per lesion. 
Histology results were retrieved from Pathology Depart-
ment and it was the Gold standard for malignancy in this 
study. 
 
The data was double entered using Epi-info version 3.2.2 
and cleaned for abnormal figures and values. The data 
was then transferred to R statistical software version 
2.7.2 for analysis. 
RESULTS 
A total of 103 patients were recruited for this study with 
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out of which 52 (50.5%) had malignant lesions. Clinical 
symptoms presented by participants were pain, mass, 
bloody nipple discharge and ulceration with frequencies 
of 77, 42, 8 and 3 respectively with some overlap of clin-
ical symptoms. Seventeen of the participants with mass 
also had pain, four of those with bloody nipple discharge 
had mass as well and the three cases with ulceration had 
mass and pain at presentation (Table 1). The overall sen-
sitivity of clinical diagnosis was 50.5%.  
 
Mammography picked 54 suspicious or highly sugges-
tive malignant lesions (BIRADS 4 AND 5) out of which, 
8 (14.8%) were histologically benign (Table 1).  
 
Table 1 Usefulness of clinical symptom for indicating di-












95% CI* +PV -PV 
Pain 77 71.2 56.9-82.9 52.9 38.5-67.1 60.7 64.3 




8 98.1 89.7-99.7 13.7 5.7-26.3 53.7 87.5 
Ulcera-
tion 
3 5.8 1.3-16.0 100 92.8-100 100 50.5 
+PV*: positive predictive value      - PV*: negative predictive value    
CI*: Confidence Interval 
 
Seventy out of the 103 participants had menarche at age 
15 and older out of which 31(44.3%) had malignant le-
sions while 33 had menarche before 15years with 21 
(63.7%) having malignant lesions. Forty seven of the 103 
participants were post-menopausal with 16 having malig-
nant lesions and 56 participants being premenopausal 
with 36 having malignant lesions. Twenty one out of the 
103 participants had no child with 16 of them having ma-
lignant lesions, 56 participants had between 1 and 5 chil-
dren with 24 malignant lesions picked among this cate-
gory while 26 had between 6 and 10 children among 
which 12 had malignant lesions. 
 
Sixty-two cases were diagnosed as suspicious or highly 
suggestive of malignancy on ultrasound (BIRADS 4 and 
5) out of which 10 (16.1%) of the lesions diagnosed as 
malignant were benign from histology, the gold standard 
for this study (Table 2).  
 
Mammogram could not make any diagnosis in 17 
(16.5%) out of the 103 cases because the breast tissue was 
dense and hence had BIRADS category 0 as the final 
mammogram diagnosis; out of this, 6 (35.3%) had malig-
nant lesions (Table 2) which were picked up on ultra-
sound.  
Table 2 Correlating proven malignant lesions to ultra-
sound and mammogram results    







tive    ( %) 
False Nega-
tive / 







False Negative /  
True Positive  
(%) 
  Category 0  
(needs additional 
imaging evalua-
tion)   
0 (0) 0 (0) 11(64.7) 6(35.3) 
Category   1 (neg-
ative- nothing to 
comment on) 
32 (100) 0 (0) 25 (100) 0(0) 
Category   2  
(Benign finding)                 
3(100) 0 (0) 5(100) 0(0) 
Category   3 
(Probably benign 
finding) 
6(100) 0 (0) 2(100) 0(0) 
Category   4 (Sus-
picious abnormal-
ity)          
8 (20) 32 (80) 8(28.6) 20 (71.4) 
Category   5  
(Highly suggestive 
of malignancy) 
2 (9.1) 20 (90.9) 0(0) 26 (100) 
 
Table 3 shows that sensitivity of ultrasonography is 
higher than that of mammography, but their specificity 
and positive predictive values are similar. 
 
Table 3 Summary of sensitivity and specificity of ultra-
sound and mammogram 
 Ultrasound Mammogram 
Sensitivity(95%CI) 100% (93.2 – 100) 73.0%(60.3-83.4) 
Specificity(95%CI) 80.4% (66.9-90.2) 80.0%(64.4 -90.9) 
Positive Predictive value 
(+PV) (95% CI) 
83.9% (72.3-92.0) 85.2% (72.9-93.4) 
Negative Predictive value (-
PV) (95% CI) 
100% (91.4-100) 65.3% (50.4-78.3) 
 
DISCUSSION 
The study has demonstrated that breast cancer diagnostic 
tools – clinical diagnosis, ultrasonography and mammog-
raphy are sensitive in identifying malignant disease. The 
proportion and age characteristics of malignant breast 
cancer cases enrolled in the study were comparable with 
a study by Wiredu et al4 and Huo et al.22 In our study the 
definition of malignancy was made using histology as the 
gold standard. Sensitivity of clinical diagnosis varied 
similar to the findings by Kolb et al.23  
 
Pain had a sensitivity of 71.2% in this study which is 
higher than in a study by Jumah et al24 in Korle Bu Teach-
ing Hospital, Ghana, where pain had an overall sensitiv-
ity of 2 %.  
The variation may be as a result of their inclusion criteria 
which did not include those with palpable masses but in 
this study, some of the cases presenting with pain in ad-
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discharge and masses. In a study by Clegg- Lamptey et 
al25, breast pain in combination with other symptoms like 
breast lump and nipple discharge when compared to 
breast pain as the sole symptom was associated with a 
higher incidence of breast cancer (16% and 1.24% re-
spectively). Patients with breast pain therefore should al-
ways have breast examination and not simply reassured. 
Early age at menarche has been known for many years to 
be associated with increased risk of breast cancer9 with 
women who first menstruated at age 15 or later having a 
23% lower risk than those with menarche prior to the age 
of 12(8); these findings are support in this study where 
63.7% of the malignant lesions picked were in people 
with menarche before 15years. There is a higher relative 
risk of 1.3% for premenopausal than menopausal women 
for breast cancer8 and this agreed with findings in this 
study where 36 of the 52 malignant lesions were in 
premenopausal women. 
 
In this study, all benign lesions (41cases) diagnosed by 
ultrasonography were benign at histology. There was a 
total of 62 (60.2%) lesions with malignant features on ul-
trasonography, out of which 52 (83.9%) were true posi-
tive and 10 (16.1%) false positive. The false positives 
were fibrocystic changes, Intraductal papillomas with fi-
brocystic change, atypical ductal hyperplasia and chronic 
inflammatory lesions. Thus ultrasonography had an over-
all sensitivity of 100% (95% CI of 93.2- 100) and a spec-
ificity of 80.4% (95%CI of 66.9-90.2) with a positive pre-
dictive value (+PV) of 83.9 and a negative predictive 
value (-PV) of 100 which are comparable with the find-
ings of Kolb et al (23) in which sensitivity, specificity, 
negative and positive predictive values and accuracy of 
ultrasonography were, 75.3%, 96.8%, 99.7%, 20.5%, and 
96.6%, respectively. 
 
Regarding mammography, 8 (14.8%) of the 54 cases with 
malignant features were histologically benign.  The sen-
sitivity of mammography to the index cancer ranges from 
63% to 98% (26) which is comparable with the overall 
sensitivity of mammogram in this study which was 
73.0% (95% CI of 60.3-83.4) and specificity of 
80.0%(95% CI of 64.4 -90.9), with a positive predictive 
value (+PV) of 85.2 and with a negative predictive value 
(-PV) of 65.3(23,27). Several studies (23,26) have shown 
decreased mammographic sensitivity in younger women, 
even after correcting for breast density.  
 
In this study where the age range was 30-94 with a mean 
age of 55(+15) years, 17 out of 103 participants (16.5%) 
required additional imaging after their mammograms 
mostly because the breast was dense and out of these 
6(35.3%) had malignant foci. Hence 6 malignancies were 
picked from dense breasts out of the 103 study partici-
pants accounting for 5.8%. It has been shown in other 
studies that increased breast density increases the risk of 
breast cancer from 2.2 to fivefold when breasts with 
densest grade are compared with fatty breasts.28,29 The 
combination of decreased mammographic sensitivity and 
increased prevalence of cancer in denser breasts has 
prompted interest in the investigation of supplemental 
screening with ultrasonography30 or even MR imaging. 
 
The sensitivity of combined mammography and ultraso-
nography in this study was 100% which is comparable to 
several studies. In the screening series of Kolb et al 23 and 
in the series of 480 symptomatic patients reported by 
Houssami et al 31, the sensitivity of combined mammog-
raphy and ultrasonography was 96% each. Moy et al 32 
reported that 97% of palpable cancers were depicted with 
a combination of ultrasonography and mammography.  
 
CONCLUSION 
In conclusion, this study has demonstrated that clinical 
diagnosis, ultrasound and mammography can potentially 
predict breast cancer disease with considerable sensitiv-
ity and specificity. The sensitivity of clinical diagnosis is 
50.5%, mammography is 73.0% and that of ultrasonog-
raphy is 100%, with a specificity of mammograms and 
ultrasound to be 80.0% and 80.4% respectively, in this 
study and hence in resource poor settings where mammo-
gram machines are scarce, and the economic costs of this 
modality present a challenge, breast ultrasound is recom-
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